These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18084683)
61. Longitudinal evaluation of a novel BChE PET tracer as an early Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675 [No Abstract] [Full Text] [Related]
62. Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease. Serdons K; Terwinghe C; Vermaelen P; Van Laere K; Kung H; Mortelmans L; Bormans G; Verbruggen A J Med Chem; 2009 Mar; 52(5):1428-37. PubMed ID: 19216563 [TBL] [Abstract][Full Text] [Related]
63. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393 [TBL] [Abstract][Full Text] [Related]
64. Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain. Cui M; Ono M; Kimura H; Liu B; Saji H Bioorg Med Chem Lett; 2011 Jul; 21(14):4193-6. PubMed ID: 21684159 [TBL] [Abstract][Full Text] [Related]
65. Differences in Aβ brain networks in Alzheimer's disease and healthy controls. Duan H; Jiang J; Xu J; Zhou H; Huang Z; Yu Z; Yan Z; Brain Res; 2017 Jan; 1655():77-89. PubMed ID: 27867033 [TBL] [Abstract][Full Text] [Related]
66. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859 [TBL] [Abstract][Full Text] [Related]
67. (18)F-Labeled benzylideneaniline derivatives as new ligands for beta-amyloid plaque imaging in Alzheimer's disease. Lee HJ; Jeong JM; Rai G; Lee YS; Chang YS; Kim YJ; Kim HW; Lee DS; Chung JK; Mook-Jung I; Lee MC Nucl Med Biol; 2009 Feb; 36(2):107-16. PubMed ID: 19217522 [TBL] [Abstract][Full Text] [Related]
68. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. Qu W; Kung MP; Hou C; Benedum TE; Kung HF J Med Chem; 2007 May; 50(9):2157-65. PubMed ID: 17411026 [TBL] [Abstract][Full Text] [Related]
70. Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's disease. Ji B; Chen CJ; Bando K; Ashino H; Shiraishi H; Sano H; Kasahara H; Minamizawa T; Yamada K; Ono M; Zhang MR; Seki C; Farde L; Suhara T; Higuchi M J Neurochem; 2015 Dec; 135(5):859-66. PubMed ID: 26315807 [TBL] [Abstract][Full Text] [Related]
71. [Amyloid-plaque imaging of the brain using PET]. Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182 [TBL] [Abstract][Full Text] [Related]
72. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain. Ono M; Yoshida N; Ishibashi K; Haratake M; Arano Y; Mori H; Nakayama M J Med Chem; 2005 Nov; 48(23):7253-60. PubMed ID: 16279784 [TBL] [Abstract][Full Text] [Related]
73. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain. Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763 [TBL] [Abstract][Full Text] [Related]
74. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains. Ono M; Cheng Y; Kimura H; Cui M; Kagawa S; Nishii R; Saji H J Med Chem; 2011 Apr; 54(8):2971-9. PubMed ID: 21428407 [TBL] [Abstract][Full Text] [Related]
75. A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging. Syvänen S; Fang XT; Hultqvist G; Meier SR; Lannfelt L; Sehlin D Neuroimage; 2017 Mar; 148():55-63. PubMed ID: 28069541 [TBL] [Abstract][Full Text] [Related]
76. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829 [TBL] [Abstract][Full Text] [Related]
77. Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain. Lee CW; Kung MP; Hou C; Kung HF Nucl Med Biol; 2003 Aug; 30(6):573-80. PubMed ID: 12900283 [TBL] [Abstract][Full Text] [Related]
78. Synthesis and evaluation of benzothiophene derivatives as ligands for imaging beta-amyloid plaques in Alzheimer's disease. Chang YS; Jeong JM; Lee YS; Kim HW; Ganesha RB; Kim YJ; Lee DS; Chung JK; Lee MC Nucl Med Biol; 2006 Aug; 33(6):811-20. PubMed ID: 16934700 [TBL] [Abstract][Full Text] [Related]
79. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease. Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062 [TBL] [Abstract][Full Text] [Related]
80. Structure-Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer's Disease Brains. Matsumura K; Ono M; Kitada A; Watanabe H; Yoshimura M; Iikuni S; Kimura H; Okamoto Y; Ihara M; Saji H J Med Chem; 2015 Sep; 58(18):7241-57. PubMed ID: 26327138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]